Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells

AIM: To assess in rodent and human adipocytes the antilipolytic capacity of hexaquis(benzylammonium) decavanadate (B6V10), previously shown to exert antidiabetic effects in rodent models, such as lowering free fatty acids (FFA) and glucose circulating levels. METHODS: Adipose tissue (AT) samples wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpéné, Christian, Garcia-Vicente, Silvia, Serrano, Marta, Marti, Luc, Belles, Chloé, Royo, Miriam, Galitzky, Jean, Zorzano, Antonio, Testar, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394734/
https://www.ncbi.nlm.nih.gov/pubmed/28465791
http://dx.doi.org/10.4239/wjd.v8.i4.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394734/
https://www.ncbi.nlm.nih.gov/pubmed/28465791
http://dx.doi.org/10.4239/wjd.v8.i4.143

Ejemplares similares